Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11/GSH/GPX4 Authors: Zhi min Huang Fu, Ming Xiao, Hailun Xie, Shuxian Zhang, Tang Yi, Qingshu Li, Ming Li, Yalan Wang Published: 2024 ABSTRACT AbstractGrowth differentiation factor 15 (GDF15) is a member of the transforming growth factor beta (TGF-β) superfamily and is related to metabolism, injury, and aging. GDF15 has both tumor-promoting and tumor-suppressing effects. However, its role in colorectal cancer (CRC) with high microsatellite instability (MSI-H) must be further clarified. In our study, we found that GDF15 is generally elevated in pancarcinoma, particularly in colorectal cancer, and serves as an early indicator of the development of colorectal cancer. IHC and WB confirmed that GDF15 was elevated in MSI-H CRC clinical tissues and MSI-H CRC cell lines (HCT-116 and LoVo). Suppressing GDF15 by siRNA resulted in a substantial decrease in cell viability and proliferation. Furthermore, suppressing GDF15 can increase the sensitivity of MSI-H CRC cells to 5-fluorouracil (5-FU), which decreases cell viability and increases the apoptosis rate. In vivo experiments also demonstrated that mouse xenografts with suppressed GDF15 expression were more susceptible to 5-FU chemotherapy. We examined alterations in mitochondria via electron microscopy and changes in the mitochondrial membrane potential, ferroptosis-related signals (MDA, Fe2+), and SLC7A11/GSH/GPX4 protein pathway. Our research indicates that inhibiting GDF15 affects ferroptosis-related pathways, leading to ferroptosis and improving the MSI-H CRC response to 5-FU therapy. As a result, GDF15 could be a promising target for diagnosing and treating MSI-H CRC, potentially enhancing the overall effectiveness of therapy for patients with MSI-H CRC.Keywords: GDF15, Microsatellite instability high, Colorectal cancer, Ferroptosis 1. Introduction The human genome contains more than 100,000 nucleotide sequences in short tandem repeat regions, known as microsatellites. Owing to the addition or deletion of repeat sequences caused by slippage during DNA replication, these microsatellites are highly reliant on deficiency in DNA mismatch repair (dMMR) for correction. High microsatellite instability (MSI-H) refers to changes in microsatellite length resulting from functional defects in the DNA mismatch repair system in tumor tissues. This can occur in various tumors such as colorectal cancer (Kim et al. 2023), gastric cancer (Puliga et al. 2021), endometrial cancer (Wang et al. 2024), ovarian cancer (Mitric et al. 2023), and others. Among them, colorectal cancer (CRC) is the most common, accounting for 15% of all colon cancers (Ganesh et al. 2019). Chemotherapy based on 5-fluorouracil (5-FU) is the first-line treatment for colorectal cancer, and 5-FU is the only chemotherapy agent that can improve patient survival at 12 months (Chen et al. 2021a, b). However, patients with MSI-H/dMMR CRC are insensitive to chemotherapy based on 5-FU, even in combination with immune checkpoint inhibitors (Tomasello et al. 2022). The objective response rate of immune checkpoint blockade treatment regimens is only about 40% (Sahin IH 2023). Many patients do not respond to immunotherapy or do not derive benefit from this treatment method. Therefore, it is essential to explore the relevant mechanisms in patients with MSI-H/dMMR CRC. Growth differentiation factor-15 (GDF15) is a member of the human body’s TGF-β superfamily located on chromosome 19. Under physiological conditions, GDF15 is either minimally expressed or absent in many organs (Johann et al. 2021). However, in the presence of inflammation, obesity, and cardiovascular disease, GDF15 can increase rapidly (Luan et al. 2019). Studies have shown that high expression of GDF15 is correlated with MSI-H status (Jayachandran et al. 2021; Lasaad and Crambert 2024). Ferroptosis is a form of programmed cell death (RCD) resulting from unrestricted lipid peroxidation and subsequent membrane damage driven by divalent iron overload (Cai and Yang 2021). Compared with adjacent and normal tissues, colorectal cancer tissue has higher levels of Fe2+ and reactive oxygen species (ROS) (Cao et al. 2019; Dixon and Stockwell 2013), and its potent antioxidant system is the key to resisting cell lethality (Li et al. 2024). Moreover, the antioxidant capacity of tumor cells can also reduce their sensitivity to chemotherapy (Dong et al. 2022). The SLC7A11/GPX4 pathway is considered a protective pathway against ferroptosis. GDF15 can resist ferroptosis by regulating the SLC7A11/GPX4 pathway in gastric cancer cells (Chen et al. 2020). On the basis of these findings, we speculated that GDF15 can regulate ferroptosis in MSI-H/dMMR CRC and affect the sensitivity of MSI-H/dMMR CRC to 5-fluorouracil. This study is the first to discuss the function of GDF15 in MSI-H/dMMR CRC and determine whether it can improve the insensitivity of MSI-H/dMMR CRC to 5-fluorouracil. We found that knockdown of GDF15 could enhance the inhibitory effect of 5-FU on MSI-H CRC by regulating the SLC7A11/GSH/GPX4 pathway. 2. Materials and methods 2.1 Bioinformatics analysis The TIMER database (http://timer.cistrome.org/) and the UCLAN database (https://ualcan.path.uab.edu/index.html) were used to analyze the expression of GDF15 across carcinomas and different stages of CRC. TCGA data were retrieved from the GEPIA database (http://gepia2.cancer-pku.cn/#analysis) to determine the transcription levels of SLC7A11 and GPX4 in CRC. 2.2 Patients and tumor specimens Thirty-eight tissue blocks of microsatellite instability-high (MSI-H) colorectal cancer and 34 tissue blocks of microsatellite stability (MSS) colorectal cancer were obtained from the Pathology Department of the First Affiliated Hospital of Chongqing Medical University from 2014 to 2021. All patients provided informed consent, and ethical approval was obtained from the Ethics Committee of Chongqing Medical University (No. 2021093). 2.3 Immunohistochemistry(IHC) The 4 μm thick tissue slices were incubated at 37 °C overnight. Subsequently, dewaxing was conducted in xylene, and dehydration was carried out via gradient ethanol. Antigen retrieval was achieved with EDTA, and endogenous peroxidase activity was blocked with 3% H2O2 in deionized water. Then, the primary antibody GDF15 (Abcam, USA) was added to the tissue section at a dilution of 1:50 and incubated overnight at 4 °C. On the next day, all slices were incubated with the secondary antibody for 20 min at 37 °C and stained with DAB (Maixing, China). Hematoxylin was used for counterstaining. The results were independently scored by two senior pathologists. The final result was a score for the percentage of positively stained cells and a score for the intensity of positive staining. The percentage of positively stained cells was determined on the basis of the proportion of 100 tumor cells observed under low magnification. The total score ranged from 0 to 4 points. A score of 0 indicated that less than 5% of the cells were positive; 1 point corresponded to 5–25%; 2 points corresponded to 25–50%; 3 points corresponded to 50–75%; and 4 points signified that more than 75% of the cells were positive. The total score for positive staining intensity ranged from 0 to 3 points: 0 points denoted no staining; 1 point indicated light yellow; 2 points indicated brown; and 3 points represented dark brown. If the sum of the above two total scores was less than 4, it was considered negative (−); 4–8 indicated weak positive (+); 8–12 denoted moderate positive (++); and more than 12 signified strong positive (+++). 2.4 Cell culture and transfection The human CRC cell line consists of MSI CRC cell lines (HCT-116 and LoVo) and MSS CRC cell lines (HT-29 and SW480), which are preserved at the Molecular Biology and Oncology Research Center of Chongqing Medical University. All the cells were cultured in DMEM (HyClone, USA) containing 12% fetal bovine serum (Gibco, USA) in an incubator maintained at 37 °C with 5% CO₂. The 2 × 106 cells were cultured in 6-well plates. When the cells reached approximately 70% confluence, in accordance with the instructions of the Lipo6000TM transfection reagent, the cells were transfected with GDF15 siRNA (the target sequence for GDF15 was as follows: 5’-GACTCCAGATTC CGAGAGT-3’). 2.5 RNA extraction and RT‒qPCR Total RNA was extracted from cells via TRIzol reagent (Takara, Japan) in accordance with the manufacturer’s instructions. The RNA was reverse transcribed to cDNA via the ABScript II cDNA First-Strand Synthesis Kit (ABclonal, #RK20400, China). Quantitative real-time PCR was performed using SYBR Green Master Mix (ABclonal, #RK21207, China). The primers used for q-PCR were as follows: for GDF15, forward primer (F): AGTCCGGATACTCACGCCAG, and reverse primer (R): CGGAACAGAGCCCGGTGAAG; for GPX4, F: GCCTTTGCCGCCTACTGAAG, and R: CGATGTCCTTGGCGGAAAAC; for SLC7A11, F: ACAGGGATTGGCTTCGTCAT, and R: AATCAACCCGCGGTACTCTT; and for GAPDH, F: ATGTTCGTCATGGGTGTGAAC, and R: ATGGACTGTGGTCATGAGTCC. 2.6 Proteins analysis The cells were seeded in triplicate in 96-well plates at a density of 4000 cells per well. In accordance with the literature (Mishra et al. 2017), 5-FU (MCE, China) was administered at a concentration of 25 µmol/ml, and the cells were cultured for 24, 48, or 72 h. Following the manufacturer’s instructions for the CCK-8 (Takara, #CK04, Japan) reagent, the cells were added to each well at a ratio of 1:9 between the CCK-8 test solution and DMEM and incubated at 37 °C for 1 h. The absorbance at 450 nm was measured via a microplate reader. 2.7 Cell viability test Cells were seeded in triplicate on 96-well plates at a density of 4000 cells per well. Referring to literature (Shi et al. 2021), 5-FU (MCE, China) was administered at a concentration of 25 µmol/ml, and cells were cultured in time gradients of 24, 48, and 72 h. Following the CCK-8 (Takara, #CK04, Japan) reagent instructions, cells were added to each well in a ratio of 1:9 between the CCK-8 test solution and DMEM and incubated at 37 °C for 1 h. Absorbance at 450 nm was measured using a microplate reader. 2.8 Flow cytometry analysis of apoptosis More than 1 × 106 of cells were collected after trypsin digestion, followed by centrifugation at 1000 × g for 3 min. The cells were washed three times with PBS. After the cell pellet was obtained and mixed with an Annexin binding solution, 10 µl of Annexin V-APC was added, and the mixture was incubated for 15 min at room temperature in the dark. Apoptosis was detected via flow cytometry. 2.9 5-Ethynyl-2’-deoxyuridine (EdU) cell proliferation assay A total of 3000 cells were seeded in 96-well plates and incubated at 37 °C and 5% CO2 for 24 h. The cells in the knockdown groups were treated with si-GDF15 transfection complexes, while those in the control groups were left untreated. In accordance with the instructions of BeyoClickTM EdU-594 reagent (Beyotime, C0078S, China), the cells were incubated in preheated EdU working solution at 37 °C per well for 24 h in an incubator and then washed and incubated with 100 µl of 0.3% Triton X-100 medium per well for 20 min at room temperature. The cells were incubated with Click reaction mixture for 30 min at 20 °C in the dark. Hoechst3342 (Beyotime, China) and PBS were used at a concentration ratio of 1:1000 for nuclear staining. The cells were photographed in the dark with a fluorescence microscope. 2.10 Measurement of intracellular Fe2+ In accordance with the manufacturer’s protocol (DOJINDO, #F374, Japan), a FerroOrange fluorescent probe was used to detect intracellular Fe2+. Briefly, 1 × 104 cells were cultured in a 24-well plate for 24 h. In the dark, a FerroOrange fluorescent probe was added to the culture plate at a final concentration of 1 µmol/l for 30 min. The cells were observed under an inverted fluorescence microscope, and ImageJ software was used to analyze the fluorescence sensitivity of intracellular Fe2+. 2.11 Measurement of the mitochondrial membrane potential (TMRE assay) After trypsin digestion, 1 × 106 cells were collected and centrifuged at 1000 × g for 3 min. The cells were resuspended in a staining working solution containing TMRE and incubated for 20–30 min at 37 °C and 5% CO2. After staining, the cells were centrifuged at 600 × g for 5 min, and the supernatant was discarded. The cells were washed twice with PBS to remove any unbound TMRE stain. The tagged cells were resuspended in PBS and examined via flow cytometry. 2.12 Measurement of glutathione (GSH) and malondialdehyde (MDA) The GSH assay reagent (Beyotime, China) was used to quantify the GSH levels. The cells were placed in 6-well plates. After intervention, the cells were collected, frozen, and thawed in a 37 °C water bath and liquid nitrogen. Following centrifugation (10,000 × g, 10 min, 4 °C) after 5 min, the supernatant was used to measure the total glutathione amount, and a microplate reader was used to determine the OD value at 412 nm. The GSH concentration (µmol/g protein) of the cells was ascertained via the following method: ((standard OD value - blank OD value)/(determined OD value - blank OD value)) * concentration of the standard tube * dilution factor for sample pretreatment ÷ protein concentration of the homogenate to be tested (g protein/L). An MDA assay reagent (Beyotime, China) was used to quantify the MDA levels. The cells were collected after cell intervention and centrifuged at 12,000 rpm for 10 min at 4 °C. The MDA working solution was boiled in a simmering water bath for 15 min. After freezing, the cells were centrifuged at 1000 rpm for 10 min at 4 °C. Two hundred microliters of each sample was transferred to a 96-well plate, and the optical density was measured at 523 nm via a microplate reader. 2.13 Transmission electron microscopy The cells were trypsinized, collected in EP tubes, treated with 2.5% glutaraldehyde, and maintained at 4 °C for at least 6 h. The fixed cells were sectioned, and the morphology of the mitochondria was examined via transmission electron microscopy. 2.14 Subcutaneous xenograft model Nude mice aged four weeks and weighing approximately 18 g were purchased from Shrek Jingda Laboratory Animal Company in Hunan Province. The mice were reared in a specific pathogen-free environment. All animal experiments were conducted in accordance with the guidelines of the Animal Ethics Committee of Chongqing Medical University. Next, 5 × 106 cells were harvested in 100 µl of PBS. The cells were implanted subcutaneously into nude mice approximately three weeks after carcinogenesis. The mice were treated with 5-FU for two weeks before being sacrificed, and the implanted tumors were collected. The weight of each group of transplanted tumors was measured. 2.15 Statistical analysis The data of this study are presented as the mean ± SEM. Each experiment was independently repeated three times. The data were statistically analyzed and plotted via SPSS 20.0 and GraphPad 6. Paired t tests, Fisher’s precision probability tests, and chi-square tests were used to compare the corresponding experiments. The results of the experiment were considered significant when the P value was less than 0.05. 3. Results 3.1. Expression and prognosis of GDF15 in MSI-H CRC cells and tissues We analyzed GDF15 mRNA levels across carcinomas via the TIMER database (Fig. 1a). Furthermore, we investigated the differential expression of GDF15 in colorectal cancer and normal tissues (Fig. 1b) and pathological stage through the UCLAN database (Fig. 1c). The pathological stage information indicated that the expression of GDF15 increased in the early stage of CRC. To explore the expression of GDF15 in MSI-H CRC, immunohistochemistry and Western blot assays were employed to validate GDF15 in vivo and in vitro. The data demonstrated that the expression of GDF15 was greater in MSI-H colorectal cancer tissues than in MSS colorectal cancer tissues (Fig. 1d–g; Table 1), and a similar result was observed in LoVo and HCT-116 cells (Fig. 1h). GDF15 is highly expressed in microsatellite instability-high colorectal cancer (MSI-H CRC) and is associated with the clinical stage of CRC. a Distribution of GDF15 expression across cancers; b expression of GDF15 in CRC tumors and normal tissues; c expression of GDF15 in the clinical stage; d–g expression of GDF15 in MSI-H CRC tissues and MSS CRC tissues; h expression of GDF15 in MSI-H CRC cells and MSS CRC cells (* P < 0.05, ** P < 0.01). *** P < 0.001) Table 1GDF15 in MSS/MSI-L CRC and MSI-H CRCGroupGDF15 Postive degreeTotal P −++++++MSI-H38101738<0.01MSS/MSI-L11128334Total1420182072 GDF15 in MSS/MSI-L CRC and MSI-H CRC 3.2 GDF15 knockdown reduces the viability and proliferation of MSI-H CRC cells We designed three siRNAs to knock down GDF15 and verified them via q-RCR and WB methods. We selected the second siRNA sequence for subsequent experiments (Fig. 2a, b). The results of the CCK-8 assay revealed that the viability of both LoVo and HCT-116 cells in the GDF15 knockdown group was significantly lower than that in the control group (Fig. 2c). The EdU assay results revealed that the percentage of GDF15-positive cells in the GDF15-knockdown group was significantly lower than that in the control group, indicating that GDF15 knockdown could reduce the proliferation ability of LoVo and HCT-116 cells (Fig. 2d). Suppression of GDF15 reduces the viability and proliferation of MSI-H colorectal cancer (CRC) cells. – a: Effect of siRNA on the protein expression of GDF15 in LoVo and HCT-116 cells; b: effect of siRNA on the mRNA expression of GDF15; c: effect of GDF15 on the viability of MSI-H CRC cells; d: effect of GDF15 on the proliferative ability of MSI-H CRC cells 3.3 GDF15 knockdown leads to decreased expression of SLC7A11 and GPX4 in MSI-H CRC cells Previous studies have indicated that GDF15 regulates the expression of SLC7A11 and GPX4. Thus, we initially utilized the GEPIA database to analyze the transcriptome levels of SLC7A11 and GPX4 in colorectal cancer and discovered that both genes were highly expressed (Fig. 3a). Subsequently, q‒PCR confirmed that knockdown of GDF15 led to decreased mRNA levels of GPX4 and SLC7A11 in both LoVo and HCT-116 cells (Fig. 3b). This finding was further corroborated by western blot assays, which demonstrated that knockdown of GDF15 decreased the protein expression of SLC7A11 and GPX4 in both LoVo and HCT-116 cells (Fig. 3c). These findings suggest that GDF15 may be involved in promoting ferroptosis in MSI-H CRC cells by regulating the SLC7A11/GPX4 axis. Suppression of GDF15 reduces the expression of SLC7A11 and GPX4 in MSI-H CRC cells. a: Transcriptome expression of SLC7A11 and GPX4 in CRC. b: Effects of GDF15 knockdown on the mRNA levels of SLC7A11 and GPX4 in LoVo and HCT-116 cells. c: Effects of GDF15 knockdown on the protein levels of SLC7A11 and GPX4 in LoVo and HCT-116 cells 3.4 GDF15 knockdown enhances the chemotherapeutic effect of 5-FU on MSI-H CRC We further investigated the impact of GDF15 expression on MSI-H CRC cells induced by 5-FU. LoVo and HCT-116 cells were treated with 5-FU for 24 h. Compared with that of cells treated with 5-FU alone or with GDF15 alone, the proliferation ability of cells with GDF15 and 5-FU knocked down was significantly lower (Fig. 4a). The flow cytometry results demonstrated that the percentage of apoptotic cells in which GDF15 and 5-FU were knocked down was also significantly greater than that in cells treated with 5-FU alone or in cells in which GDF15 was knocked down alone (Fig. 4b). To further investigate whether the knockdown of GDF15 expression augments the chemotherapeutic effect of 5-FU on MSI-H CRC, we carried out animal experiments for in vivo observation. Nude mice were injected with 5-FU every other day for 14 days. Compared with the group treated with 5-FU alone, the group treated with GDF15 knockdown and 5-FU presented a delay in the growth, volume and weight of the transplanted tumors (Fig. 4c). Suppression of GDF15 enhances the chemotherapeutic effects of 5-FU in vivo and in vitro . a: Effects of GDF15 on the viability of LoVo and HCT-116 cells after 5-FU treatment. b: Effect of GDF15 on the apoptosis of LoVo and HCT-116 cells after 5-FU treatment. c: Effects of GDF15 and 5-FU treatment on tumor volume and weight in mice 3.5 Knockdown of GDF15 enhanced the sensitivity of MSI-H CRC cells to ferroptosis induced by 5-FU To further explore whether GDF15 contributes to the increased susceptibility of MSI-H CRC cells to 5-FU treatment, we assessed ferroptosis-related parameters. LoVo and HCT-116 cells were treated with 25 µmol/ml 5-FU for 24 h. The FerroOrange fluorescent probe revealed a significant increase in Fe²⁺ levels in 5-FU-treated LoVo and HCT-116 cells following GDF15 suppression (Fig. 5a). The flow cytometry results confirmed that GDF15 knockdown in cells exposed to 5-FU resulted in a decrease in the mitochondrial membrane potential, thereby increasing chemotherapy sensitivity (Fig. 5b). This heightened sensitivity was linked to increased Fe²⁺ release from the mitochondria, leading to an imbalance in iron homeostasis. Knockdown of GDF15 enhances the tumor-suppressive effect of 5-FU by modulating ferroptosis. a: Effects of GDF15 on the cellular Fe2 + levels of LoVo and HCT-116 cells after 5-FU treatment. b: Effects of GDF15 on the mitochondrial membrane potential of LoVo and HCT-116 cells after 5-FU treatment. c: Effects of GDF15 on the MDA levels of LoVo and HCT-116 cells after 5-FU treatment. d: Effects of GDF15 on the GSH levels in LoVo and HCT-116 cells after 5-FU treatment. e: Effects of GDF15 on SLC7A11 and GPX4 expression in LoVo and HCT-116 cells after 5-FU treatment. f: Effects of GDF15 on pathological changes in mitochondria in LoVo and HCT-116 cells after 5-FU treatment MDA, a byproduct of lipid peroxidation, serves as an indicator of ferroptosis and exacerbates cellular injury through interactions with macromolecules. Our findings suggest that GDF15 knockdown elevates MDA levels and that the combination of 5-FU treatment and GDF15 knockdown in LoVo and HCT-116 cells further increases MDA levels (Fig. 5c). GSH plays a crucial role in ferroptosis, as it is a common intracellular tripeptide with potent antioxidant properties. The SLC7A11 protein regulates GSH production, protecting cells from ferroptosis, and GSH also serves as a substrate for GPX4, an enzyme responsible for clearing lipid peroxides. In both LoVo and HCT-116 cells, downregulation of GDF15 led to decreased SLC7A11 protein levels, reduced GSH production, and decreased GPX4 protein expression. Notably, GDF15 knockdown combined with 5-FU treatment further diminished GSH production (Fig. 5d), GPX4 protein expression, and SLC7A11 protein levels (Fig. 5e). Our research indicates that GDF15 enhances sensitivity to 5-FU by modulating ferroptosis in MSI-H cells through the SLC7A11/GSH/GPX4 pathway. Mitochondria serve as the primary energy providers in cells. Excessive iron can induce ferroptosis, adversely affecting mitochondrial structure and function. We examined alterations in mitochondrial structure in LoVo and HCT-116 cells via transmission electron microscopy. Our observations revealed that features of ferroptosis were more pronounced in the group with GDF15 knockdown and 5-FU exposure than in the groups with only GDF15 knockdown or 5-FU treatment alone. The combination of GDF15 knockdown and 5-FU exposure resulted in a reduction in the number of mitochondrial cristae, an increase in the mitochondrial membrane density, and disruption of the mitochondrial outer membrane (Fig. 5f). 4. Discussion In this study, we observed that GDF15 levels were consistently elevated across various cancers, as indicated by the TIMER database, and were significantly increased in colorectal cancer patients during the early stages of tumorigenesis. Western blotting and immunohistochemistry confirmed the high expression of GDF15 in clinical tissue samples and cell lines (HT-29, SW480, LoVo, and HCT-116). Furthermore, colorectal tissues and cells with high microsatellite instability presented higher levels of GDF15 expression than did those with high microsatellite stability. Findings from Priya’s research, which included genome sequencing analysis of more than 7200 colorectal cancer patients, suggest a strong correlation between GDF15 levels and the MSI-H subtype (Jayachandran et al. 2021). However, the study did not delve further into the specific role of GDF15 in MSI-H CRC. Our analysis of 72 clinical tissue samples and 4 cell lines revealed elevated GDF15 protein levels in MSI-H CRC compared with microsatellite stable CRC. To further investigate its role in MSI-H CRC, we employed siRNA techniques to downregulate GDF15 expression and assess its impact on cell viability. The results indicated that GDF15 suppression led to reduced viability and proliferation in both LoVo and HCT-116 cells, suggesting that elevated GDF15 expression stimulates proliferation in MSI-H CRC cells. The resistance of tumor cells to chemotherapy presents a significant challenge in cancer treatment, and our findings may offer a potential solution. Several studies have demonstrated that modulating ferroptosis markers can increase the sensitivity of cells to chemotherapy (Shen et al. 2024; Yang et al. 2024). GDF15 has been implicated in the regulation of ferroptosis (Li et al. 2023; Yang et al. 2023). Any factor that influences SLC7A11, GSH, or GPX4 can lead to the accumulation of lipid peroxides within cells, triggering ferroptosis (Ye et al. 2022; Zhang et al. 2024). Therefore, these factors are critical for maintaining the cellular redox balance and preventing ferroptosis. Our examination of the TCGA database revealed that the mRNA levels of SLC7A11 and GPX4 were significantly elevated in colorectal cancer tissues compared with normal tissues. Additionally, we confirmed that GDF15 knockdown resulted in decreased expression of SLC7A11 and GPX4 in LoVo and HCT-116 cells. These findings suggest that GDF15 may influence key ferroptosis-related proteins in MSI-H CRC cells. The underlying mechanisms involving GDF15, SLC7A11, and GPX4 warrant further investigation in future studies. We also explored whether GDF15 could modulate the susceptibility of MSI-H CRC to 5-FU. As a chemotherapeutic agent, 5-FU inhibits purine and pyrimidine biosynthesis, disrupting DNA synthesis and ultimately impeding cancer cell growth and division (Biller and Schrag 2021). While 5-FU is a cornerstone of neoadjuvant chemotherapy for colorectal cancer, previous research has indicated that patients with MSI-H CRC do not experience survival benefits from 5-FU treatment (Akbari et al. 2019; Li et al. 2022). To assess changes in chemosensitivity, we treated LoVo and HCT-116 cells with 5-FU and suppressed GDF15 expression. The results demonstrated that GDF15 knockdown significantly reduced cell viability during 5-FU exposure. Flow cytometry analysis revealed that knocking down GDF15 in conjunction with 5-FU treatment resulted in the highest apoptotic rate. Animal experiments further confirmed that, compared with control mice, GDF15-knockdown mice presented significantly lower tumor weights and volumes. These findings suggest that GDF15 suppression enhances the sensitivity of MSI-H CRC cells to 5-FU treatment. Previous studies have indicated that GDF15 suppression can regulate epithelial‒mesenchymal transition and apoptosis, contributing to 5-FU resistance in colon cancer cells (Wang et al. 2020). Our findings also indicate that inhibiting GDF15 reduces MSI-H CRC proliferation while enhancing the inhibitory effects of 5-FU. Our research investigated the potential molecular mechanisms linking ferroptosis and chemoresistance regulated by GDF15. Fe2+ plays a crucial role in maintaining iron balance within cells. When cells take up iron ions, they convert them to Fe2+, which is subsequently absorbed by mitochondria to synthesize iron‒sulfur clusters and heme. A reduction in the mitochondrial membrane potential can lead to the leakage of iron ions into the cytoplasm, increasing free intracellular iron levels, particularly Fe2+ (Hamdi et al. 2016). This may trigger the Fenton reaction, generating additional hydroxyl radicals that can increase lipid peroxidation and cause cellular damage (Ferreyra et al. 2024). We utilized a FerroOrange fluorescent probe and flow cytometry to assess changes in Fe2+ levels and the mitochondrial membrane potential in LoVo and HCT-116 cells. Following treatment with 5-FU and GDF15 knockdown, we observed a significant increase in the intracellular Fe2+ level, accompanied by a notable reduction in the membrane potential, suggesting that elevated Fe2+ levels may be linked to mitochondrial release. GPX4 plays a protective role against lipid peroxidation mediated by intracellular iron overload, utilizing GSH as a reducing agent to neutralize lipid peroxides. When SLC7A11 levels are decreased, GSH synthesis is inhibited, leading to decreased intracellular GSH levels. Over the years, SLC7A11 and GPX4 have collaborated to establish a robust cellular antioxidant defense mechanism in ferroptosis (Xin Chen et al. 2021a, b). GPX4 dysfunction can result in lipid peroxide accumulation and subsequent ferroptosis. Our study demonstrated that when cells were treated with 5-FU and GDF15 was knocked down, intracellular GSH levels were significantly lower than those in cells with GDF15 knockdown alone, with considerable reductions in GPX4 and SLC7A11 protein levels. We also observed pathological changes in mitochondria, confirming that GDF15 knockdown can enhance chemosensitivity to 5-FU by promoting ferroptosis. Transmission electron microscopy revealed more pronounced mitochondrial damage, including mitochondrial pyknosis, increased membrane density, loss of mitochondrial cristae, and rupture of the outer mitochondrial membrane, in cells with GDF15 knockdown exposed to 5-FU. On the basis of these findings, we propose that GDF15 may increase the responsiveness of MSI-H CRC cells to 5-FU by regulating the GPX4/GSH/SLC7A11 pathway. Given the potential for drug resistance and the need to improve the efficacy of conventional chemotherapy regimens, our results indicate that combining GDF15 suppression with 5-FU therapy significantly enhances the drug’s inhibitory effects. Furthermore, inhibiting GDF15 improved the sensitivity of MSI-H CRC cells to 5-FU through modulation of the GPX4/GSH/SLC7A11 pathway. Author contributions Zhi Min Huang Fu’s contributions to the head of the project were the initial idea, original draft, writing review, and editing. Ming Xiao and Hailun Xie’s contribution to investigation, method-ology, and data curation. Shuxian Zhang and Qingshu Li’s contribution to conceptualization and formal analysis. Yalan Wang’s contribution to coordination. Ming Li’s contributions to supervi-sion, project administration, and funding acquisition. Funding This research was funded by the Chongqing Education Committee Science and Technology Research Project, grant number X4557. Institutional Review Board Statement: All patients provided informed consent, and the study was conducted in accordance with the Declaration of Helsinki guidelines. The procedures were approved by the Clinical Research Ethics Committee of Chongqing Medical University (No. 2021093). Data availability No datasets were generated or analysed during the current study. Declarations Conflict of interest There are no conflicts of interest associated with this manuscript. Informed consent Informed consent was obtained from all the subjects involved in the study. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Ming Li, Email: 500309@hospital.cqmu.edu.cn. Yalan Wang, Email: wangyalan@cqmu.edu.cn. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.